These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2. Ibarra C; Amaral MM; Palermo MS IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500 [TBL] [Abstract][Full Text] [Related]
24. Recent Updates on Outbreaks of Shiga Toxin-Producing Kim JS; Lee MS; Kim JH Front Cell Infect Microbiol; 2020; 10():273. PubMed ID: 32582571 [TBL] [Abstract][Full Text] [Related]
26. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981 [TBL] [Abstract][Full Text] [Related]
27. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Freedman SB; Xie J; Neufeld MS; Hamilton WL; Hartling L; Tarr PI; ; Nettel-Aguirre A; Chuck A; Lee B; Johnson D; Currie G; Talbot J; Jiang J; Dickinson J; Kellner J; MacDonald J; Svenson L; Chui L; Louie M; Lavoie M; Eltorki M; Vanderkooi O; Tellier R; Ali S; Drews S; Graham T; Pang XL Clin Infect Dis; 2016 May; 62(10):1251-1258. PubMed ID: 26917812 [TBL] [Abstract][Full Text] [Related]
28. Excitotoxicity in encephalopathy associated with STEC O-157 infection. Ishida S; Yasukawa K; Koizumi M; Abe K; Hirai N; Honda T; Sakuma H; Tada H; Takanashi JI Brain Dev; 2018 Apr; 40(4):357-360. PubMed ID: 29248444 [TBL] [Abstract][Full Text] [Related]
29. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [TBL] [Abstract][Full Text] [Related]
33. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage. Luna M; Kamariski M; Principi I; Bocanegra V; Vallés PG Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220 [TBL] [Abstract][Full Text] [Related]
35. Molecular Characterization of Shiga Toxin-Producing Escherichia coli Strains Isolated in Poland. Januszkiewicz A; Rastawicki W Pol J Microbiol; 2016 Aug; 65(3):261-269. PubMed ID: 29334059 [TBL] [Abstract][Full Text] [Related]
36. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100 [TBL] [Abstract][Full Text] [Related]
37. Hemoglobinuria for the early identification of STEC-HUS in high-risk children: data from the ItalKid-HUS Network. Capone V; Mancuso MC; Tamburini G; Montini G; Ardissino G Eur J Pediatr; 2021 Sep; 180(9):2791-2795. PubMed ID: 33759020 [TBL] [Abstract][Full Text] [Related]
38. Molecular Biology of Menge C Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456125 [TBL] [Abstract][Full Text] [Related]